Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir

Nature Medicine(2025)10.1038/s41591-024-03357-0Source: DataRank Database

Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir is a research paper published in Nature Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

gen refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.33)OA: greenTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Jana Blažková ORCID,Lela Kardava,J. Shawn Justement,Victoria Shi ORCID,Maegan R. Manning

Live enrichment

PubMed:39753965 PMC:PMC12120854 OpenAlex:https://openalex.org/W4406034634

Intramural NIH HHS

Grant: Z01 AI000851

Intramural NIH HHS

Grant: ZIA BC010888

NIH HHS

Grant: S10 OD028540

NIAID NIH HHS

Grant: UM1 AI164565

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1S10OD028540-01

Small Molecule Biomarker Core: TSQ Altis LC-MS/MS

National Institutes of Health

Grant: 5UM1AI164565-05

REACH: Research Enterprise to Advance a Cure for HIV

FWCI

2.33

Citation Percentile

0.9%

Citation Trend

2025

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12120854/pdf/nihms-2080014.pdf

publisherhttps://www.nature.com/articles/s41591-024-03357-0.pdf

publisherhttps://www.nature.com/articles/s41591-024-03357-0

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12120854

Fields of Study

HIV Research and TreatmentHIV/AIDS drug development and treatmentImmune Cell Function and Interaction0303 health sciences03 medical and health sciencesHumansMaleMiddle AgedHIV InfectionsDrug Resistance, Multiple, ViralHIV-1Anti-HIV AgentsCD4 Lymphocyte CountCD4 AntigensAntibodies, Monoclonal, HumanizedAcetamidesIndazoles

MeSH Terms

Sustained Virologic ResponseAcetamidesHumansIndazolesMaleMiddle AgedSarcoma, KaposiHIV-1HIV InfectionsCD4 AntigensCD4 Lymphocyte CountAnti-HIV AgentsDrug Resistance, Multiple, ViralAntibodies, Monoclonal, Humanized

Keywords

ViremiaMultiple drug resistanceHuman immunodeficiency virus (HIV)VirologyAntibodyImmunologyRegimenSarcomaMedicineCapsidAntiretroviral therapyVirusBiologyViral loadDrug resistanceInternal medicinePathologyGeneticsMaleIndazolesAnti-HIV AgentsHIV InfectionsMiddle AgedAntibodies, Monoclonal, HumanizedCD4 Lymphocyte CountDrug Resistance, Multiple, ViralCD4 AntigensAcetamidesHIV-1Humans

Sustainable Development Goals

SDG 0: Good health and well-being

Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir

FAIR Checklist

Authors (24)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)